Olympus Corporation

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$3.1Mgeneral payments (2019-2025)
$0.00research payments (2019-2025)
264clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $529K
2020 $229K
2021 $138K
2022 $166K
2023 $432K
2024 $904K
2025 $729K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Gastroenterology (Internal Medicine) $2.3M
Colon & Rectal Surgery $164K
Surgical Oncology $106K
Surgery $97K
Pulmonary Disease $87K
Thoracic Surgery (Cardiothoracic Vascular Surgery) $48K

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Robert Hawes Orlando, FL Gastroenterology (Internal Medicine) $231,157.40
Gregory Ginsberg Philadelphia, PA Gastroenterology (Internal Medicine) $174,561.39
Tonya Kaltenbach Palo Alto, CA $165,338.58
Douglas Rex Indianapolis, IN Gastroenterology (Internal Medicine) $152,012.31
Steven Edmundowicz Aurora, CO Gastroenterology (Internal Medicine) $138,368.87
Christopher Gostout Rochester, MN Gastroenterology (Internal Medicine) $109,948.91
Vanessa Shami Charlottesville, VA Gastroenterology (Internal Medicine) $84,973.36
Nikhil Kumta New York, NY Gastroenterology (Internal Medicine) $71,395.44
Shelby Sullivan Lebanon, NH Gastroenterology (Internal Medicine) $65,828.50
Peter Draganov Gainesville, FL Gastroenterology (Internal Medicine) $57,802.94

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.